Frovatriptan

From Free net encyclopedia

[[Image:{{{image\|Frovatriptan.png}}}\|{{{width\|220}}}px\|Frovatriptan chemical structure]] Frovatriptan
6-methylamino-6,7,8,9-tetrahydro -5H-carbazole-3-carboxamide IUPAC name
CAS number 158930-17-7	}}}
PubChem 5284561	DrugBank APRD00270
Chemical formula	C₁₄H₁₇N₃O
Molecular weight	243.304 g/mol
Bioavailability	20-30%
Metabolism	Hepatic
Elimination half-life	26 hours
Excretion	Renal
Pregnancy category	C: (USA) B3: (AUS)
Legal status	Prescription only
Routes of administration	Oral

Frovatriptan (Frova®) is a triptan drug developed by Endo Pharmaceuticals for the treatment of migraine headaches. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. It is available as 2.5 mg tablets.

Frovatriptan has mean terminal elimination half-life of approximately 26 hours, which is substantially longer than for other triptans.

Frovatriptan is available only by prescription in the United States.

[edit]